Specialty Pharmacy Videos

Cheryl Allen, BSPharm, MBA, Vice President of Industry Relations at Diplomat Pharmacy, gives an overview of the exciting therapeutic developments in the B-cell lymphoma space.
Nick Calla, RPh, vice president of Industry Relations at Cardinal Health Specialty Solutions, talks about how technology can enhance patient care from a pharmacy perspective.
Doris Quon, MD, Medical Director at the Orthopaedic Hemophilia Treatment Center, discusses the main takeaways from phase 3 HAVEN trial data for emicizumab (Hemlibra) prophylaxis in hemophilia.
A look at last week's top stories in the world of pharmacy.
Nick Calla, RPh, vice president of Industry Relations at Cardinal Health Specialty Solutions, talks about how different providers must work together to ensure the success of a value-based care system.
Tim Boonstra, RPh, Pharmacy Manager at Fairview Center for Bleeding and Clotting Disorders, discusses the collaborative approach taken at his clinic in the management and treatment of patients with hemophilia.

Peer Exchange

PEER EXCHANGE > Advances and Best Practices in the Utilization of Novel Agents in Metastatic Breast Cancer
Based on positive feedback on the use of CDK4/6 inhibitors as treatment for metastatic breast cancer, Sara M. Tolaney, MD, MPH, and Lindsay Shaw, NP, remark on strategies for improving adherence to these oral therapies.
PEER EXCHANGE > Advances and Best Practices in the Utilization of Novel Agents in Metastatic Breast Cancer
The value in counseling patients and healthcare professionals on the proper use of CDK4/6 inhibitors for the treatment of metastatic breast cancer.
PEER EXCHANGE > Patient Accessibility of Oral Oncolytics for CLL
After reviewing the status of oral oncolytics across disease states, the panel considers the specific logistical processes involved in chronic lymphocytic leukemia.
PEER EXCHANGE > Advances and Best Practices in the Utilization of Novel Agents in Metastatic Breast Cancer
Practical considerations for ensuring that appropriate patients with breast cancer receive and use their oral oncolytic therapies as prescribed.

Insights

INSIGHTS > Patient Selection and Safety with TNF Inhibitors
Clinical expertise on the use of corticosteroids and mesalamine-based products in the management of autoimmune diseases.
INSIGHTS > Patient Selection and Safety with TNF Inhibitors
Criteria and the significance of biomarkers to help healthcare professionals avoid a misdiagnosis of an autoimmune disorder, such as an inflammatory bowel disease.
INSIGHTS > Understanding Axial Spondyloarthritis
Atul A. Deodhar, MD, explains why axial spondyloarthritis is challenging to diagnose and reinforces the need for educational efforts to help raise awareness among patients and the healthcare community and improve how the condition is managed.
INSIGHTS > Understanding Axial Spondyloarthritis
Typical patient symptoms and diagnostic criteria used to accurately confirm the diagnosis of axial spondyloarthritis.

Most Popular

Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$